Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
Silvia Pesce, Marco Greppi, Giovanna Tabellini, et al.
Journal of Allergy and Clinical Immunology (2016) Vol. 139, Iss. 1, pp. 335-346.e3
Open Access | Times Cited: 410

Showing 1-25 of 410 citing articles:

Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers, Jeffrey S. Miller
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 85-100
Open Access | Times Cited: 916
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2019) Vol. 49, Iss. 10, pp. 1457-1973
Open Access | Times Cited: 874
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4654-4668
Open Access | Times Cited: 665
Guidelines for the use of flow cytometry and cell sorting in immunological studies*
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 10, pp. 1584-1797
Open Access | Times Cited: 507
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez, Maxime Meylan, Aurélien de Reyniès, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 467
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Simona Sivori, Paola Vacca, Genny Del Zotto, et al.
Cellular and Molecular Immunology (2019) Vol. 16, Iss. 5, pp. 430-441
Open Access | Times Cited: 417
Revisiting the PD-1 pathway
Nikolaos Patsoukis, Qi Wang, Laura Strauss, et al.
Science Advances (2020) Vol. 6, Iss. 38
Open Access | Times Cited: 400
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette Ma, Wan‐Teck Lim, Boon Cher Goh, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 14, pp. 1412-1418
Open Access | Times Cited: 376
Tumor-Infiltrating Natural Killer Cells
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, et al.
Cancer Discovery (2020) Vol. 11, Iss. 1, pp. 34-44
Open Access | Times Cited: 347
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende, Michela Falco, Massimo Vitale, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 324
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 12, pp. 2708-3145
Open Access | Times Cited: 314
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Yuan Liu, Yufeng Cheng, Yong Xu, et al.
Oncogene (2017) Vol. 36, Iss. 44, pp. 6143-6153
Open Access | Times Cited: 313
NK cell-based immunotherapy for cancer
Fang Fang, Weihua Xiao, Zhigang Tian
Seminars in Immunology (2017) Vol. 31, pp. 37-54
Closed Access | Times Cited: 277
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 277
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi‐Ferchiou, Marion Lambert, Stéphanie Dogniaux, et al.
Oncotarget (2016) Vol. 7, Iss. 45, pp. 72961-72977
Open Access | Times Cited: 274
NK Cell Exhaustion
Jiacheng Bi, Zhigang Tian
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 259
The Mechanism of Anti–PD-L1 Antibody Efficacy against PD-L1–Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Wenjuan Dong, Xiaojin Wu, Shoubao Ma, et al.
Cancer Discovery (2019) Vol. 9, Iss. 10, pp. 1422-1437
Open Access | Times Cited: 252
NK cells and ILCs in tumor immunotherapy
Simona Sivori, Daniela Pende, Linda Quatrini, et al.
Molecular Aspects of Medicine (2020) Vol. 80, pp. 100870-100870
Open Access | Times Cited: 193
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins, S. Khan, Maria M. Park, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3499-3510
Open Access | Times Cited: 184
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Takashi Nakamura, Takanori Sato, Rikito Endo, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002852-e002852
Open Access | Times Cited: 184
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
Beatriz Sánchez-Correa, Isabel Valhondo, Fakhri Hassouneh, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 877-877
Open Access | Times Cited: 181
Targeting tumor microenvironment in ovarian cancer: Premise and promise
Yuting Jiang, Chengdi Wang, Shengtao Zhou
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1873, Iss. 2, pp. 188361-188361
Closed Access | Times Cited: 163
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Carlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 161
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
Silvia Pesce, Marco Greppi, Francesco Grossi, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 156
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
Sean J. Judge, William J. Murphy, Robert J. Canter
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 155
Page 1 - Next Page

Scroll to top